Benefits of Lutein

Evidence-Based Benefits

• Macular degeneration protection — the AREDS2 trial (n=4,203) demonstrated that lutein 10 mg + zeaxanthin 2 mg was a safe and effective replacement for beta-carotene in reducing advanced AMD risk by ~18% over 5 years
• Blue light filtration — lutein absorbs 40-90% of incident blue light in the macula, reducing phototoxic damage to photoreceptors (Bernstein et al., 2016)
• Contrast sensitivity — a 2017 meta-analysis of 20 RCTs found lutein supplementation significantly improved macular pigment optical density (MPOD) and visual contrast sensitivity
• Cataract risk reduction — the Nurses Health Study and Health Professionals Follow-Up Study found those in the highest quintile of lutein/zeaxanthin intake had an 18-22% lower risk of cataracts
• Cognitive support — higher macular pigment density is correlated with better cognitive function in older adults, suggesting neuroprotective effects

What the Research Says

Lutein has robust clinical evidence, anchored by the AREDS2 trial (2013, JAMA, n=4,203), which established lutein 10 mg + zeaxanthin 2 mg as the preferred carotenoid combination for AMD. A 10-year follow-up confirmed lutein/zeaxanthin was superior to beta-carotene for reducing late AMD risk by approximately 20%. Epidemiological data consistently associates higher lutein intake with reduced risk of both AMD and cataracts.

Related Conditions